Reply to SGLT-2 inhibitors: Post-infarction interventional effects
Saved in:
Main Authors: | Pasquale Paolisso (Author), Luca Bergamaschi (Author), Felice Gragnano (Author), Emanuele Gallinoro (Author), Arturo Cesaro (Author), Celestino Sardu (Author), Niya Mileva (Author), Alberto Foà (Author), Matteo Armillotta (Author), Angelo Sansonetti (Author), Sara Amicone (Author), Andrea Impellizzeri (Author), Giuseppe Esposito (Author), Nuccia Morici (Author), Oreglia Jacopo Andrea (Author), Gianni Casella (Author), Ciro Mauro (Author), Dobrin Vassilev (Author), Nazzareno Galie (Author), Gaetano Santulli (Author), Raffaele Marfella (Author), Paolo Calabrò (Author), Emanuele Barbato (Author), Carmine Pizzi (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2023-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effects of Sodium-Glucose Transporter 2 Inhibitors (SGLT2-I) in Patients With Ischemic Heart Disease (IHD) Treated by Coronary Artery Bypass Grafting via MiECC: Inflammatory Burden, and Clinical Outcomes at 5 Years of Follow-Up
by: Celestino Sardu, et al.
Published: (2021) -
Editorial: Hyperglycemia and Coronary Artery Diseases: Physio-Pathological Findings and Therapeutic Implications
by: Raffaele Marfella, et al.
Published: (2022) -
Secondary Prevention Medical Therapy and Outcomes in Patients With Myocardial Infarction With Non-Obstructive Coronary Artery Disease
by: Pasquale Paolisso, et al.
Published: (2020) -
COVID-19 Causes Ferroptosis and Oxidative Stress in Human Endothelial Cells
by: Stanislovas S. Jankauskas, et al.
Published: (2023) -
Preliminary Experience With Low Molecular Weight Heparin Strategy in COVID-19 Patients
by: Pasquale Paolisso, et al.
Published: (2020)